Autopsy report · NCT02482909

A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma

“The post-treatment recurrence rate was expected to be different between two treatment groups.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 years 11 months after it had already started.
• Ran for about 8 years before it stopped.
• 68 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Seoul National University Hospital

Sponsor type

University, hospital or other

Conditions

Carcinoma, Hepatocellular

Interventions

Hepatic resection; Radiofrequency ablation

Participants

68

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.